- Home
- JMSB vs IMMP Comparison
JMSB vs IMMP Comparison
Compare JMSB & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JMSB
- IMMP
- Stock Information
- Founded
- JMSB 2005
- IMMP 1987
- Country
- JMSB United States
- IMMP Australia
- Employees
- JMSB N/A
- IMMP N/A
- Industry
- JMSB Major Banks
- IMMP Biotechnology: Pharmaceutical Preparations
- Sector
- JMSB Finance
- IMMP Health Care
- Exchange
- JMSB Nasdaq
- IMMP Nasdaq
- Market Cap
- JMSB 276.5M
- IMMP 251.8M
- IPO Year
- JMSB N/A
- IMMP N/A
- Fundamental
- Price
- JMSB $19.03
- IMMP $2.07
- Analyst Decision
- JMSB Buy
- IMMP Buy
- Analyst Count
- JMSB 2
- IMMP 1
- Target Price
- JMSB $22.50
- IMMP $7.00
- AVG Volume (30 Days)
- JMSB 16.2K
- IMMP 93.3K
- Earning Date
- JMSB 10-22-2025
- IMMP 10-10-2025
- Dividend Yield
- JMSB 1.58%
- IMMP N/A
- EPS Growth
- JMSB 688.28
- IMMP N/A
- EPS
- JMSB 1.32
- IMMP N/A
- Revenue
- JMSB $56,750,000.00
- IMMP $3,306,742.00
- Revenue This Year
- JMSB $18.36
- IMMP $16.82
- Revenue Next Year
- JMSB $12.36
- IMMP N/A
- P/E Ratio
- JMSB $14.42
- IMMP N/A
- Revenue Growth
- JMSB 59.00
- IMMP 31.28
- 52 Week Low
- JMSB $13.81
- IMMP $1.32
- 52 Week High
- JMSB $26.52
- IMMP $2.71
- Technical
- Relative Strength Index (RSI)
- JMSB 40.76
- IMMP 70.72
- Support Level
- JMSB $19.25
- IMMP $1.75
- Resistance Level
- JMSB $19.90
- IMMP $2.09
- Average True Range (ATR)
- JMSB 0.56
- IMMP 0.08
- MACD
- JMSB -0.18
- IMMP 0.04
- Stochastic Oscillator
- JMSB 0.00
- IMMP 92.63
About JMSB John Marshall Bancorp Inc.
John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.